Dr Scott Smid
Cannabis in the Gut and inflammation

Dr Scott Smid is a pharmacologist specialising in preclinical drug discovery and development research in both industry and academic settings. He maintains a strong research interest in experimental therapeutics applied towards novel treatments for gastrointestinal and neurodegenerative diseases. This includes investigating the biological actions of phytocannabinoids, synthetic cannabinoids and endocannabinoids in areas as diverse as gut function, inflammation and neurodegeneration. He has received US and Australian research funding to investigate the potential of cannabinoids as novel treatments for inflammation and dementia and has scientific advisory and education roles to government, industry and representative bodies for medical cannabis in Australia.